Trial Profile
Study comparing the in-stent responses between bioabsorbable polymer everolimus-eluting stent (BP-EES) and durable polymer everolimus-eluting stent (DP-EES) using coronary angioscopy (CAS) and optical coherence tomography (OCT).
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Sep 2018
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- 19 Sep 2018 New trial record
- 29 Aug 2018 Results presented at the ESC Congress 2018: Annual Congress of the European Society of Cardiology